22
DELIRIUM Lindsay Trantum ACNP-BC VUMC Neuroscience ICU

DELIRIUM

  • Upload
    kael

  • View
    124

  • Download
    5

Embed Size (px)

DESCRIPTION

DELIRIUM. Lindsay Trantum ACNP-BC VUMC Neuroscience ICU. Objectives. By the end of the presentation…… Identify the key features of delirium Identify risk factors for delirium Demonstrate understanding of the treatment plan for delirium. Delirium = Brain Dysfunction. - PowerPoint PPT Presentation

Citation preview

Page 1: DELIRIUM

DELIRIUM

Lindsay Trantum ACNP-BCVUMC Neuroscience ICU

Page 2: DELIRIUM

Objectives

• By the end of the presentation……– Identify the key features of delirium– Identify risk factors for delirium– Demonstrate understanding of the treatment plan

for delirium

Page 3: DELIRIUM

Delirium = Brain Dysfunction• Definition: DSM IV officially defines delirium

as a disturbance of consciousness with inattention accompanied by a change in cognition or perceptual disturbance that develops over a short period of time (hours to days) and fluctuates over time

• “The 6th vital sign”

Page 4: DELIRIUM

Subtypes• Hyperactive– characterized by agitation, restlessness, and

emotional lability

• Hypoactive– decreased responsiveness, withdrawal, and

apathy

• Mixed– Periods of hyperactivity and lethargy

Page 5: DELIRIUM

Incidence

• 60%-80% of mechanically ventilated patients• 50%-70% of non-ventilated patients• Hypoactive delirium = 43.5%• Hyperactive delirium = 1.6%• Mixed delirium = 54.1%

(Girard, 2008)

Page 6: DELIRIUM

Outcomes• 3 fold increase in 6 month mortality• 1 in 3 delirium survivors develop permanent

cognitive impairment• Associated with…..– New nursing home placement– Increased length of stay > 8.0 days– Increased mortality– Increased number of days on the ventilator

Page 7: DELIRIUM

Outcomes Continued….

• Associated with…….– Depression/PTSD– Increased risk of aspiration– Increased need for re-intubation– Increased hospital cost: national burden $38

billion/year

(Ely, 2004); (Inouye, 1998)

Page 8: DELIRIUM

Risk Factors• I WATCH DEATH (many acronyms)– Infection – Withdrawl (Etoh, Sedatives)– Acute Metabolic (renal/liver failure, electrolytes, etc)– Trauma– CNS Pathology– Hypoxia– Deficiencies (B12, thiamine, folate, niacin)– Endocrine (hyper/hypo)– Acute vascular– Toxins– Heavy metals

Page 9: DELIRIUM

Pathophysiology

• Multi-factorial and poorly understood• Neurotransmitter imbalance– Dopamine (excess) & acetlycholine (depleation)– Results in neuroexcitability and unpredictable

synapses– GABA, serotonin, endorphins and glutamate

Page 10: DELIRIUM

Pathophysiology

• Inflammation– Inflammatory mediators cross blood-brain barrier

and increase vascular permeability– Result = decrease cerebral blood flow (CBF)• Platelets, fibrin, neutrophils obstruct CBF

(Gunther, 2008)

Page 11: DELIRIUM

Monitoring• Step 1: RASS= Richmond Agitation Sedation

Scale– RASS goal– Actual RASS– Minimize Sedation

• Step 2: CAM-ICU = Confusion Assessment Method– Takes approximately 1 minute– Sensitivity/Specificity 95%

Page 12: DELIRIUM

Targets 4 Key FeaturesTargets 4 Key FeaturesFeature 1: Acute onset of mental

status changes, or Fluctuating course.

Feature 2: Inattention

AND

AND

Feature 3: Disorganised thinking

Feature 4: Altered level of consciousnessOR

Page 13: DELIRIUM

CAM-ICU Worksheet

Page 14: DELIRIUM

CAM-ICU Video

• http://www.youtube.com/watch?v=1hSDNOVHMVs

Page 15: DELIRIUM

Management of Delirium• Environmental– Early mobility– Maintaining a day/night cycle

• Minimize light/noise• Promoting sleep at night

– Assessing for extubation– Daily sedation interruption– Correct hearing/visual deficits

• Hearing aids• Glasses/magnifying glasses

Page 16: DELIRIUM

Management of Delirium• Pharmacologic Options (intubated)– Sedation choices• Pain relief?

– Morphine, fentanyl, dilaudid• Sedation?

– Dexamedatomidine» Not for patients that need RASS -2 or greater

– Propofol– Avoid benzodiazepines except in ETOH withdrawal

Page 17: DELIRIUM

Management of Delirium• Pharmacologic Options (non-intubated)– Antipsychotics• Haldol 2.5-10mg q2h prn

– Monitor daily EKG• Add Seroquel 25mg BID and titrate by 25mg q12h• Zyprexa• Dex

– Benzodiazepines• Don’t use unless managing ETOH withdrawal

Page 18: DELIRIUM

Delirium Timeline

• Usually seen within the first 24 to 48 hrs• Can last as long as 2 weeks or longer– Be patient

Page 19: DELIRIUM

Questions????

Page 20: DELIRIUM

Resources

Icudelirium.orgSurgicalcriticalcare.net

Page 21: DELIRIUM

Delirium Review Article

Page 22: DELIRIUM

References• Girard, Timothy; Pandharipande, Pratik; Ely, Wesley; (2008). Delirium in

the Intensive Care Unit.; Critical Care. 12 (Suppl 3); S3• Gunther, Max, L.; Morandi, Alessandro; Ely, Wesley; (2008)

Pathophysiology of Delirium in the ICU. Critical Care Clinics. 24: 45-6• Inouye, S. et al. (1998). Does delirium contribute to poor hospital

outcomes? A three-site epidemiological study. Journal of General Internal Medicine. 13(4): 234-42.

• Ely, EW et al. (2004). Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 14; 291 (14): 1753-62.

• Barr, J. et al. (2013). Clinical Practice Guidelines for the Management of Pain, Agitation and Delirium in Adult Patients in the Intensive Care Unit. Critical Care Medicine. Jan 41(1): 263-306.

• Cheatham, M.D. (Jan 4, 2011); Delirium Management Guidelines. Retrieved from http://www.surgicalcriticalcare.net/Guidelines/delirium_2011.pdf